Showing results (331-340 of 793) with videos related to

Sort By:
Pageof 80
Cancer Cell International|August 29, 2020
Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma disseminationZhenhai Li, Shaji Kumar, Dong-Yan Jin, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemiaRobert A Kyle, Terry M Therneau, Angela Dispenzieri, et al.
Cancer|October 10, 2013
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategiesBrian L Burnette, Angela Dispenzieri, Shaji Kumar, et al.
British Journal of Haematology|February 21, 2006
FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myelomaShaji Kumar, Noopur Raje, Teru Hideshima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasmsAlla Keyzner, Anita D'Souza, Martha Lacy, et al.
The Lancet. Haematology|December 23, 2014
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort studyRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.
Blood|March 28, 2012
Progression in smoldering Waldenstrom macroglobulinemia: long-term resultsRobert A Kyle, Joanne T Benson, Dirk R Larson, et al.
Pageof 80